Figure 2
From: Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
Anti-coagulation clotting pathway proteins that were altered in women with polycystic ovary syndrome (PCOS). Levels of plasma prothrombin (A), Vitamin K dependent Protein S (B) and heparin cofactor II in women with and without polycystic ovary syndrome (PCOS). RFU, relative fluorescent units. Graphs shown as mean ± SEM. ^p < 0.05, **p < 0.001, ***p < 0.0001.
